Endocrinology in the time of COVID-19: Management of Cushing’s syndrome

Newell-Price, J., Nieman, L.K., Reincke, M. et al. (1 more author) (2020) Endocrinology in the time of COVID-19: Management of Cushing’s syndrome. European Journal of Endocrinology, 183 (1). G1-G7. ISSN 0804-4643

Abstract

Metadata

Authors/Creators:
  • Newell-Price, J.
  • Nieman, L.K.
  • Reincke, M.
  • Tabarin, A.
Copyright, Publisher and Additional Information: © 2020 European Society of Endocrinology. This is an author-produced version of a paper subsequently published in European Journal of Endocrinology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Coronavirus Infections; Cushing Syndrome; Disease Management; Enzyme Inhibitors; Glucocorticoids; Humans; Hydrocortisone; Immunocompromised Host; Infection Control; Ketoconazole; Metyrapone; Neurosurgical Procedures; Pandemics; Patient Education as Topic; Pneumonia, Viral; Practice Guidelines as Topic; Severity of Illness Index; Telemedicine; Time Factors
Dates:
  • Accepted: 20 April 2020
  • Published (online): 24 June 2020
  • Published: July 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 24 Jun 2020 15:58
Last Modified: 30 Jun 2020 12:53
Status: Published
Publisher: Bioscientifica
Refereed: Yes
Identification Number: https://doi.org/10.1530/eje-20-0352
Related URLs:

Share / Export

Statistics